Legal Representation
Attorney
Rosemary Weaver McKenna
USPTO Deadlines
Next Deadline
74 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-10-01)
Due Date
October 01, 2025
Grace Period Ends
April 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 17, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Mar 17, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Mar 17, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Nov 19, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Oct 1, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Oct 1, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 16, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 16, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 26, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 12, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 7, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 5, 2019 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jun 4, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 4, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2019 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jun 4, 2019 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Apr 29, 2019 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 29, 2019 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 11, 2018 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Sep 11, 2018 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Sep 11, 2018 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Sep 11, 2018 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Sep 4, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 22, 2018 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 19, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 15, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical drug development services, pharmaceutical research services, pharmaceutical product evaluation, conducting early evaluations in the field of new pharmaceuticals, consultancy pertaining to pharmacology, pharmacokinetic and pharmacokinetic-pharmacodynamic studies and analyses relating to drug development
First Use Anywhere:
Dec 31, 2015
First Use in Commerce:
Dec 31, 2015
Additional Information
Design Mark
The mark consists of the letter "I", followed by the letters "CPD" contained within a stylized box, with the words "INSTITUTE FOR CLINICAL" below that, and the word "PHARMACODYNAMICS" below that.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
INSTITUTE FOR CLINICAL PHARMACODYNAMICS INSTITUTE FOR CLINICAL PHARMACODYNAMICS
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"INSTITUTE FOR CLINICAL PHARMACODYNAMICS"